title: Molecular targets for breast cancer therapy and prevention.
abstract: The recent completion of the human genome sequence has raised great hopes for the discovery of new breast cancer therapies based on newly-discovered genes linked to breast cancer development and progression. Here we describe breast cancer therapies that have emerged from gene-based scientific efforts over the past 20 years and that are now approved for clinical testing or treatment.
authors.affiliation: Max-Planck-Institut of Biochemistry, Department of Molecular Biology Martinsried, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Bange
authors.forename: E
authors.initials: E
authors.lastname: Zwick
authors.forename: A
authors.initials: A
authors.lastname: Ullrich
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000235:genetics* / Q000517:prevention & control; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D009389:Neovascularization, Pathologic / Q000517:prevention & control
chemical_list: D020533:Angiogenesis Inhibitors